Showing 821-830 of 20873 results for "".
- Transforming Cancer Screening: The Potential of the Galleri Blood Testhttps://reachmd.com/news/transforming-cancer-screening-the-potential-of-the-galleri-blood-test/2484016/A single ctDNA blood test now demonstrates multi-cancer detection capability with a high specificity and a majority of detections at stage I–II, expanding early-stage identification beyond current single-organ screens. This was determined by the
- Emerging Therapies in Proteinuria: Pegcetacoplan and Atrasentan Lead the Chargehttps://reachmd.com/news/emerging-therapies-in-proteinuria-pegcetacoplan-and-atrasentan-lead-the-charge/2475642/Persistent proteinuria and progressive loss of renal function in disorders like C3 glomerulopathy and immune-complex–mediated membranoproliferative glomerulonephritis represent a critical blind spot in nephrology, yet the clinical landscape i
- Study Highlights Role of Patient-Reported Outcomes in Botulinum Toxin Developmenthttps://reachmd.com/news/study-highlights-role-of-patient-reported-outcomes-in-botulinum-toxin-development/2475414/A patient-centric clinical approach, driven by the evolution of patient-reported outcomes (PROs), has been central to the development of onabotulinumtoxinA for aesthetic indications, according to new research in the Journal of Cosmetic Dermatology. Researchers concluded there is i
- AI and Neuroprognosis: Transforming Critical Care with Machine Learninghttps://reachmd.com/news/ai-and-neuroprognosis-transforming-critical-care-with-machine-learning/2475396/AI and Neuroprognosis: Transforming Critical Care with Machine Learning Accurate early prognostication in traumatic spinal cord injuries remains challenging, limiting neurologists' ability to tailor interventions and i
- The Shifting Landscape of Primary Care: Hospital and Private Equity Affiliations Transforming Practicehttps://reachmd.com/news/the-shifting-landscape-of-primary-care-hospital-and-private-equity-affiliations-transforming-practice/2474852/In recent years, primary care has experienced a profound transformation as hospitals and private equity firms increasingly affiliate with providers, altering the financial and operational dynamics of healthcare delivery. Primary care i
- Andropause: Exploring Hormonal Changes in Aging Menhttps://reachmd.com/news/andropause-exploring-hormonal-changes-in-aging-men/2474732/Aging introduces significant endocrine shifts in men that are vital to understanding the male aging process. A pivotal finding is the gradual reduction in testosterone, akin to hormonal changes during menopause. Recognizing this shift i
- Decoding the Genetic and Epigenetic Landscape of Polycystic Ovary Syndromehttps://reachmd.com/news/gene-alterations-and-their-role-in-polycystic-ovary-syndrome/2474598/Polycystic ovary syndrome (PCOS) is a prevalent and complex endocrine disorder, impacting up to 20% of women of reproductive age worldwide. Recent advances in genomics and epigenetics are unraveling the intricate biological mechanisms behind its development. These i
- Genetic Predictive Modeling in Pancreatic Cancer: Refined Patient Selection for Surgeryhttps://reachmd.com/news/genetic-predictive-modeling-in-pancreatic-cancer-refined-patient-selection-for-surgery/2474364/An innovative Japanese predictive model utilizes genetic data with traditional tumor markers to improve survival predictions and optimize surgical decisions in advanced pancreatic cancer. Overview of the Predictive Model Breakthroughs i
- Medical Marijuana: Managing Cancer-related Symptomshttps://reachmd.com/news/medical-marijuana-managing-cancer-related-symptoms/2474275/A recent meta-analysis indicates that medical marijuana provides much-needed relief for cancer patients by alleviating symptoms such as pain, appetite loss, and nausea. However, the Schedule I classification of cannabis has historically hindered comprehensive resear
- Secukinumab Reduces Erosions in Psoriatic Arthritis Patientshttps://reachmd.com/news/secukinumab-reduces-erosions-in-psoriatic-arthritis-patients/2471713/Secukinumab significantly reduced erosion progression in patients with psoriatic arthritis (PsA), according to findings from a phase 4 randomized, double-blind, placebo-controlled trial. The study evaluated the impact of the I